Digirad Corporation Announces Attendance at Upcoming Investor Conferences
September 17 2019 - 6:00AM
Digirad Corporation (NASDAQ: DRAD; DRADP) (“Digirad” or the
“Company”), a diversified holding company, announced that
representatives of the Company will be presenting its holding
company (“HoldCo”) strategy at the following conferences in New
York City:
- Tuesday, September 17: MicroCap Fall Investor Summit at
the JW Marriott Essex House (main presentation is scheduled
for 10:00am ET)
- Wednesday, September 25: Sidoti Conference at the Grand
Hyatt Hotel (main presentation is scheduled for 2:10pm
ET)
- Monday, October 7: LD Micro Conference
A copy of the investor presentation is available
in the Investor Relations section of Digirad's website at
http://ir.digirad.com/static-files/1d66f5ff-11c9-496b-a86b-94c2fc74312b.
About Digirad Corporation
Digirad Corporation is a diversified holding
company with three operating business divisions: Healthcare
Imaging, Building & Construction and Real Estate &
Investment Management.
Digirad: Healthcare Imaging
Division
Digirad Health designs, manufactures, and
distributes diagnostic medical imaging products. Digirad
Health operates in three businesses: Diagnostic
Services, Mobile Healthcare, and Diagnostic Imaging. The
Diagnostic Services business offers imaging and monitoring services
to healthcare providers as an alternative to purchasing the
equipment or outsourcing the job. The Mobile
Healthcare business provides contract diagnostic imaging,
including computerized tomography (“CT”), magnetic resonance
imaging (“MRI”), positron emission tomography (“PET”), PET/CT, and
nuclear medicine and healthcare expertise through a convenient
mobile service. The Diagnostic Imaging business develops, sells,
and maintains solid-state gamma cameras.
ATRM Holdings: Building &
Construction Division
ATRM manufactures modular housing units for
commercial and residential applications. ATRM operates in two
businesses: (i) modular building manufacturing and (ii) structural
wall panel and wood foundation manufacturing, including building
supply retail operations. The modular building manufacturing
business is operated by KBS Builders, the structural wall panel and
wood foundation manufacturing business is operated by EdgeBuilder,
and the retail building supplies are sold through Glenbrook Lumber.
KBS Builders, EdgeBuilder and Glenbrook Lumber are wholly-owned
subsidiaries of ATRM.
Real Estate & Investment Management
Division
This business manages real estate assets
(currently three manufacturing plants in Maine) and investment
funds.
Forward-Looking Statements
“Safe Harbor” Statement under the Private
Securities Litigation Reform Act of 1995: This presentation
contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. All statements in
this presentation that are not statements of historical fact are
hereby identified as “forward-looking statements” for the purpose
of the safe harbor provided by Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended. Forward-looking Statements include, without
limitation, statements regarding (i) the plans and objectives of
management for future operations, including plans or objectives
relating to acquisitions and related integration, development of
commercially viable products, novel technologies, and modern
applicable services, (ii) projections of income (including
income/loss), EBITDA, earnings (including earnings/loss) per share,
free cash flow (FCF), capital expenditures, cost reductions,
capital structure or other financial items, (iii) the future
financial performance of Digirad Corporation (“Digirad,” “DRAD” or
the “Company”) or acquisition targets and (iv) the assumptions
underlying or relating to any statement described above. Moreover,
forward-looking statements necessarily involve assumptions on the
Company’s part. These forward-looking statements generally
are identified by the words “believe”, “expect”, “anticipate”,
“estimate”, “project”, “intend”, “plan”, “should”, “may”, “will”,
“would”, “will be”, “will continue” or similar expressions.
Such forward-looking statements are not meant to predict or
guarantee actual results, performance, events or circumstances and
may not be realized because they are based upon the Company's
current projections, plans, objectives, beliefs, expectations,
estimates and assumptions and are subject to a number of risks and
uncertainties and other influences, many of which the Company has
no control over. Actual results and the timing of certain
events and circumstances may differ materially from those described
above as a result of these risks and uncertainties. Factors
that may influence or contribute to the inaccuracy of
forward-looking statements or cause actual results to differ
materially from expected or desired results may include, without
limitation, the substantial amount of debt of the Company and the
Company’s ability to repay or refinance it or incur additional debt
in the future; the Company’s need for a significant amount of cash
to service and repay the debt and to pay dividends on the Company
Preferred Stock; the restrictions contained in the debt agreements
that limit the discretion of management in operating the business;
the length of time associated with servicing customers; losses of
significant contracts; disruptions in the relationship with third
party vendors; accounts receivable turnover; insufficient cash
flows and resulting illiquidity; the Company's inability to expand
the Company's business; unfavorable changes in the extensive
governmental legislation and regulations governing healthcare
providers and the provision of healthcare services and the
competitive impact of such changes (including unfavorable changes
to reimbursement policies); high costs of regulatory compliance;
the liability and compliance costs regarding environmental
regulations; the underlying condition of the technology support
industry; the lack of product diversification; development and
introduction of new technologies and intense competition in the
healthcare industry; existing or increased competition; risks to
the price and volatility of the Company’s Common Stock and
Preferred Stock; stock volatility and illiquidity; risks to
preferred stockholders of not receiving dividends and risks to the
Company’s ability to pursue growth opportunities if the Company
continues to pay dividends according to the terms of the Company
Preferred Stock; the Company’s ability to execute on its business
strategy (including any cost reduction plans); the Company’s
failure to realize expected benefits of restructuring and
cost-cutting actions; the Company’s ability to preserve and
monetize its net operating losses; risks associated with the
Company’s possible pursuit of acquisitions; the Company’s ability
to consummate successful acquisitions and execute related
integration, including to successfully integrate ATRM’s operations
and realize the synergies from the acquisition, as well as factors
related to the Company’s business (including ATRM) including
economic and financial market conditions generally and economic
conditions in the Company’s markets; failure to keep pace with
evolving technologies and difficulties integrating technologies;
system failures; losses of key management personnel and the
inability to attract and retain highly qualified management and
personnel in the future; and the continued demand for and market
acceptance of the Company’s services. For a detailed
discussion of cautionary statements and risks that may affect the
Company’s future results of operations and financial results,
please refer to the Company’s filings with the Securities and
Exchange Commission, including, but not limited to, the risk
factors in the Company’s most recent Annual Report on Form 10-K and
Quarterly Reports on Form 10-Q. This presentation reflects
management’s views as of the date presented.
All forward-looking statements are necessarily only estimates of
future results, and there can be no assurance that actual results
will not differ materially from expectations, and, therefore, you
are cautioned not to place undue reliance on such statements.
Further, any forward-looking statement speaks only as of the date
on which it is made, and we undertake no obligation to update any
forward-looking statement to reflect events or circumstances after
the date on which the statement is made or to reflect the
occurrence of unanticipated events.
For more information contact: |
|
Digirad Corporation |
Investor Relations |
Chairman of the Board |
The Equity Group |
Jeffrey E. Eberwein |
Lena Cati |
203-489-9501 |
212-836-9611 |
ir@digirad.com |
lcati@equityny.com |
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Sep 2023 to Sep 2024